Advisory
Committee for Pharmaceutical Science and Clinical Pharmacology (ACPS-CP)
July 22, 2008
SLIDES
TOPIC 1:
Nanotechnology in Drug Manufacturing, Drug Delivery, and Drug Products
Food and Drug Administration Presentations
Helen
Winkle, Director, OPS/CDER/FDA (ppt)
(html)
Keith O.
Webber, Ph.D., Deputy Director, OPS/CDER/FDA (ppt) (html)
Guest Speaker Presentations
Lawrence
Tamarkin, Ph.D., President
and CEO, CytImmune Sciences, Inc. (ppt)
(html)
Stephen B.
Ruddy, Ph.D., Elan Corporation (ppt)
(html)
Darin Y.
Furgeson, Ph.D., University of Wisconsin-Madison (pdf)
TOPIC 2:
Lead in Pharmaceutical Products
Food and Drug Administration Presentations
Norman R.
Schmuff, Ph.D., ONDQA/OPS/CDER/FDA (ppt)
(html)
Susan K.
Cummins, M.D., MPH, PMHS/OND/CDER/FDA (ppt)
(html)
John F.
Kauffman, Ph.D., DPA/OTR/OPS/CDER/FDA (ppt)
(html)
Michael E.
Kashtock, Ph.D., OFS/CFSAN/FDA (ppt)
(html)
Guest Speaker Presentation
Darrell R. Abernethy,
M.D.,
Ph.D.
,
U.S.
Pharmacopeia (ppt) (html)
Up
| AC Home Page